Literature DB >> 16139917

Phenotypic expression in detected C282Y homozygous women depends on body mass index.

Fabrice Lainé1, Anne-Marie Jouannolle, Jeff Morcet, Alain Brigand, Michel Pouchard, Bernard Lafraise, Jean Mosser, Véronique David, Yves Deugnier.   

Abstract

BACKGROUND/AIMS: In HFE-related haemochromatosis, a large proportion of C282Y homozygotes, especially women, are not detected by phenotypic screening using transferrin saturation. The aim of this study was to identify the clinical and biochemical factors associated with non-expression of the disease as defined as transferrin saturation <45%.
METHODS: The study was performed in 78 (57 women and 21 men) C282Y homozygotes identified through a large-scale screening program conducted on 19,644 French subjects. Biometric, clinical and biochemical variables including those susceptible to influence body iron stores were tested for association with transferrin saturation levels <45%.
RESULTS: Non-expression was observed in 26/57 (46%) women and in 5/21 (24%) men. At multivariate analysis, female gender (OR: 16.5, 95%CI 1.8-146.5; P = 0.012), body mass index (OR: 1.21, 95%CI 1.02-1.44; P = 0.027), haemoglobin levels (OR: 0.88, 95%CI 0.81-0.97; P = 0.012) and serum ferritin levels (OR: 0.99, 95%CI 0.98-1.00; P = 0.007) were significantly and independently associated with a non-expressing phenotype.
CONCLUSIONS: Excess body mass is commonly associated with the lack of phenotypic expression in detected C282Y homozygotes. This should be kept in mind with respect to the design and cost-effectiveness of phenotypic screening programs for haemochromatosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139917     DOI: 10.1016/j.jhep.2005.05.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

Review 1.  Hepcidin and iron homeostasis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Biochim Biophys Acta       Date:  2012-01-26

Review 2.  Diabetes and hemochromatosis.

Authors:  T Creighton Mitchell; Donald A McClain
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

3.  Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.

Authors:  Bo Qiao; Priscilla Sugianto; Eileen Fung; Alejandro Del-Castillo-Rueda; Maria-Josefa Moran-Jimenez; Tomas Ganz; Elizabeta Nemeth
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

4.  Prohepcidin and iron metabolism parameters in the obese elderly patients with anemia.

Authors:  J Przybyszewska; E Zekanowska; K Kedziora-Kornatowska; J Boinska; R Cichon; K Porzych
Journal:  J Nutr Health Aging       Date:  2011-04       Impact factor: 4.075

5.  Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2.

Authors:  Sara Pelucchi; Raffaella Mariani; Paola Trombini; Sabina Coletti; Matteo Pozzi; Valentina Paolini; Donatella Barisani; Alberto Piperno
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

6.  Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.

Authors:  James C Barton; Ronald T Acton; Catherine Leiendecker-Foster; Laura Lovato; Paul C Adams; John H Eckfeldt; Christine E McLaren; Jacob A Reiss; Gordon D McLaren; David M Reboussin; Victor R Gordeuk; Mark R Speechley; Richard D Press; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

7.  Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation.

Authors:  Rodolphe Anty; Monsef Dahman; Antonio Iannelli; Philippe Gual; Aline Staccini-Myx; Imed Ben Amor; Nathalie Luciani; Marie-Christine Saint-Paul; Pierre-Michel Huet; Jean-Louis Sadoul; Surjit Kaila S Srai; Robert Unwin; Jean Gugenheim; Yannick Le Marchand-Brustel; Albert Tran; Soumeya Bekri
Journal:  Obes Surg       Date:  2008-03-11       Impact factor: 4.129

8.  What are genes "for" or where are traits "from"? What is the question?

Authors:  Anne V Buchanan; Samuel Sholtis; Joan Richtsmeier; Kenneth M Weiss
Journal:  Bioessays       Date:  2009-02       Impact factor: 4.345

9.  Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome.

Authors:  Alessia Riva; Paola Trombini; Raffaella Mariani; Alessandra Salvioni; Sabina Coletti; Silvia Bonfadini; Valentina Paolini; Matteo Pozzi; Rita Facchetti; Giorgio Bovo; Alberto Piperno
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

10.  Prognostic associations of plasma hepcidin in women with early breast cancer.

Authors:  Katarzyna J Jerzak; Ana E Lohmann; Marguerite Ennis; Elizabeta Nemeth; Tomas Ganz; Pamela J Goodwin
Journal:  Breast Cancer Res Treat       Date:  2020-09-22       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.